Actively Recruiting
Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units: A Randomized, Controlled, Cluster, Crossover Clinical Trial
Led by Hospital Israelita Albert Einstein · Updated on 2026-04-15
5000
Participants Needed
12
Research Sites
N/A
Total Duration
On this page
Sponsors
H
Hospital Israelita Albert Einstein
Lead Sponsor
H
Hospital Sirio-Libanes
Collaborating Sponsor
AI-Summary
What this Trial Is About
Healthcare-associated infections (HAIs) are a significant issue in intensive care units (ICUs), often caused by environmental contamination with multidrug-resistant organisms that remain despite regular cleaning. Researchers are evaluating two advanced disinfection methods—hydrogen peroxide aerosolization and ultraviolet-C light—to reduce this contamination. This cluster-randomized, crossover trial will be conducted in 12 Brazilian ICUs to compare these methods with usual surface disinfection practices. The trial includes three sequential cleaning strategies for each ICU: usual surface disinfection alone; usual disinfection followed by hydrogen peroxide aerosolization at 7.9% concentration applied inside a protective tent during terminal cleaning of beds; and usual disinfection followed by automated ultraviolet-C irradiation applied under the same tent. The protective tent is used to prevent exposure of adjacent beds and ICU areas to the disinfecting agents. Participants will be all patients aged 18 years and older admitted to these ICUs. Researchers will measure antimicrobial use at the ICU level over three months, daily defined doses per 100 patient-days, and secondary outcomes such as rates of HAIs, contamination by multidrug-resistant organisms, specific infections like ventilator-associated pneumonia, bloodstream infections, urinary tract infections, and ICU length of stay costs. Safety and effectiveness of surface disinfection methods will be monitored throughout the study.
CONDITIONS
Brief Title
Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years and older admitted to participating intensive care units
You will not qualify if you...
- Patients under 18 years of age
- Intensive care units already using hydrogen peroxide or ultraviolet light for surface disinfection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 months
Participants are exposed to different surface disinfection methods in the ICU, including aerosolized hydrogen peroxide, ultraviolet light irradiation, or usual disinfection protocols.
Ongoing exposure during ICU stay
Duration - Up to 3 months
Participants are monitored for healthcare-associated infections and other outcomes related to ICU stay and disinfection methods.
Assessments conducted during and after ICU stay as part of routine care
Trial Site Locations
Total: 12 locations
1
Hospital Maternidade Sao Vicente De Paulo
Barbalha, Ceará, Brazil
Actively Recruiting
2
Instituto Hospital de Base
Brasília, Federal District, Brazil
Actively Recruiting
3
Hospital Estadual de Aparecida de Goiânia
Aparecida de Goiânia, Goiás, Brazil
Actively Recruiting
4
Santa Casa de Misericórdia de Passos
Passos, Minas Gerais, Brazil
Actively Recruiting
5
Fundo Municipal de Saúde de Maringá
Maringá, Paraná, Brazil
Actively Recruiting
6
Hospital da Restauração
Recife, Pernambuco, Brazil
Actively Recruiting
7
Hospital Universitário da Universidade Federal do Piauí
Teresina, Piauí, Brazil
Actively Recruiting
8
Hospital Universitário Onofre Lopes
Natal, Rio Grande do Norte, Brazil
Actively Recruiting
9
Hospital Geral de Caxias do Sul
Caxias do Sul, Rio Grande do Sul, Brazil
Actively Recruiting
10
Hospital de Pronto Socorro de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Actively Recruiting
11
Hospital Dr Leo Orsi Bernardes
Itapetininga, São Paulo, Brazil
Actively Recruiting
12
Hospital Pelópidas Silveira
Recife, Brazil
Actively Recruiting
Research Team
A
Antonio P Nassar Jr, PhD
A
Adriano J Pereira, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here